ACCESS PACK EXPO XPRESS ONLINE TODAY. Content is available on-demand through November 30th.

Study Shows CBD Reduces Anxiety in Young People

The non-psychoactive derivative of cannabis nearly cut chronic anxiety problems in half in people ages 12 to 25.

Shutterstock 1093553171

A recent Medical News Today article discussed a study that shed light on one of the benefits of cannabidiol (CBD), the part of cannabis that doesn’t produce a mind-altering effect. The study included 31 people between the ages 12 and 25 who met the criteria for a DSM-5 anxiety disorder and were unable to improve their condition with other treatments. Over a period of 12 weeks, participants received doses as high as 800 mg/d. By the end of the three months, participants saw a 40% decrease in anxiety severity based on the Overall Anxiety Severity and Impairment Scale.

The author of the study, Professor Paul Amminger said, “There’s a lot of hope that a novel compound which is benign, like cannabidiol, could ease mental health problems. I think that the most exciting finding of the study was that the anxiety severity, which was on average severe to very severe, dropped by 50% at the end of the trial.” The results were promising, but not without side effects. Some participants experienced low mood, fatigue, cold chills, and hot flashes but no major adverse events.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts